Stock Market Update - April 1, 2026
Today's stock market saw some significant movers. Here's a breakdown of 5 stocks that caught our attention:
1. CYCN - Cyclerion Therapeutics, Inc.
Price: $6.38 | Change: +311.61% ($4.83)
CYCN surged an incredible 311.61% following a significant announcement on April 1, 2026. Cyclerion Therapeutics, Inc. revealed a definitive all-stock merger agreement with privately-held Korsana Biosciences, Inc., immediately triggering a pre-market share price increase of over 160%.
This transaction is essentially a reverse takeover. When the deal closes in the third quarter of 2026, the combined entity will operate as Korsana Biosciences, Inc. and trade on Nasdaq under the new ticker symbol "KRSA." Current Cyclerion stockholders are anticipated to own approximately 1.5% of the merged company, with Korsana's existing shareholders controlling the vast majority.
What makes this particularly noteworthy is the substantial financial backing for Korsana, which secured an oversubscribed private financing round totaling approximately $380 million. This funding is expected to finance the new company's operations into 2029, as it focuses on advancing a pipeline of therapeutics for neurodegenerative diseases, including a lead program targeting Alzheimer's. This merger represents a significant strategic shift, fueled by fresh capital and a clear new direction.
2. ELAB - PMGC Holdings Inc.
Price: $14 | Change: +133.72% ($8.01)
ELAB:NASDAQ surged an impressive 133.72% around early April 2026, fueled by a wave of positive company announcements. The primary catalyst came from its biotech subsidiary, NorthStrive Biosciences, which delivered exciting news regarding its therapeutic candidates.
NorthStrive announced a critical amendment to a licensing agreement, potentially allowing its EL-22 and EL-32 muscle preservation treatments to bypass early-stage clinical trials and advance directly to Phase 2. This acceleration in development timelines is expected to save significant time and capital. Adding to the investor enthusiasm, parent company PMGC Holdings Inc. also reported strong fiscal year 2025 financial results, including a robust 43% increase in total assets, boosted by strategic acquisitions.
Further enhancing investor confidence, PMGC's AGA Precision Systems unit secured a new five-year aerospace defense supply agreement. What makes ELAB's recent movement particularly interesting is this blend of progress: a potentially transformative biotech pipeline combined with solid growth and strategic deals in its precision manufacturing and defense sectors.
3. AGPU - Axe Compute Inc.
Price: $3.56 | Change: +119.75% ($1.94)
AGPU saw an incredible 119.75% gain around April 2, 2026, after Axe Compute Inc. announced significant new enterprise agreements. These contracts, totaling approximately $12 million, are projected to bring in $835,000 in monthly income as the company moves into the second quarter of 2026, translating to about $7.5 million in estimated income for the rest of 2026.
This massive stock surge reflects Axe Compute's strategic pivot to becoming an enterprise GPU infrastructure company, providing high-performance computing resources specifically for artificial intelligence workloads. The agreements cover various advanced GPU architectures, from RTX 5090 to H100 and B200, and are structured with monthly upfront payments to ensure predictable and recurring revenue.
What's particularly interesting is how these contracts validate the company's recent rebranding from Predictive Oncology in December 2025. This strong commercial traction in its new core AI compute segment has clearly fueled investor optimism and directly drove the substantial rise in AGPU's stock price.
4. POAI - Predictive Oncology Inc.
Price: $3.21 | Change: +98.15% ($1.59)
POAI (recently rebranded as AGPU) saw an incredible 98.15% surge after announcing a major strategic pivot towards AI GPU infrastructure and digital assets. Despite reporting a significant net loss from its previous oncology business, the company successfully raised $343.5 million through private investments.
This substantial capital infusion was used to establish a "Strategic Compute Reserve" and secure marketplace access to over 435,000 GPUs globally, indicating a strong move into the burgeoning AI compute sector. This aggressive shift effectively transformed its balance sheet from a stockholders' deficit to $47.7 million in equity.
Investors appear to be prioritizing the company's bold entry into AI-driven compute resources and its active digital asset management strategy, signaling optimism for its new direction despite the legacy business's losses.
5. MGRT - Mega Fortune Company Limited
Price: $12.26 | Change: +89.78% ($5.8)
MGRT just posted an eye-popping nearly 90% gain around April 2, 2026! Mega Fortune Company Limited saw its stock price surge dramatically to $12.26. This rapid ascent was so intense that it triggered multiple trading halts on April 1, a mechanism designed to calm extreme volatility in the market.
What makes MGRT's impressive leap particularly interesting is the absence of a clear catalyst. Unlike typical surges driven by major news like a new product, partnership, or stellar earnings, reports around this period don't pinpoint any specific corporate announcement behind the climb. This unexplained spike, combined with some after-hours trading showing dips, highlights the highly volatile nature of its recent activity. All eyes might now be on their upcoming earnings report scheduled for April 14, 2026, which could provide more clarity.
This analysis was generated using AI and real-time stock data. Always do your own research before making investment decisions.